Company Valuation: AstraZeneca PLC

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 182,034 209,442 209,268 203,171 287,813 248,994 - -
Change - 15.06% -0.08% -2.91% 41.66% -13.49% - -
Enterprise Value (EV) 1 206,417 232,365 231,778 227,741 311,187 268,775 261,303 253,073
Change - 12.57% -0.25% -1.74% 36.64% -13.63% -2.78% -3.15%
P/E 1,469x 64.1x 35.4x 29.1x 28.4x 20.6x 17.9x 15.6x
PBR 4.24x 5.65x 5.39x 5.02x 5.96x 4.62x 4.1x 3.48x
PEG - 0x 0.4x 1.6x 0.6x 1.1x 1.2x 1x
Capitalization / Revenue 4.87x 4.72x 4.57x 3.76x 4.9x 3.94x 3.72x 3.49x
EV / Revenue 5.52x 5.24x 5.06x 4.21x 5.3x 4.25x 3.91x 3.55x
EV / EBITDA 27.2x 25.2x 17.1x 13.6x 16x 12.1x 10.7x 9.46x
EV / EBIT 20.8x 17.4x 15.9x 13.5x 16.8x 12.7x 11.2x 9.9x
EV / FCF 42.4x 26.7x 25.8x 22.9x 26.5x 28x 20.2x 17.6x
FCF Yield 2.36% 3.75% 3.88% 4.36% 3.78% 3.57% 4.94% 5.68%
Dividend per Share 2 2.87 2.9 2.9 3.1 3.2 3.325 3.527 3.662
Rate of return 2.44% 2.15% 2.15% 2.37% 1.72% 2.07% 2.2% 2.28%
EPS 2 0.08 2.11 3.81 4.5 6.54 7.8 8.957 10.31
Distribution rate 3,588% 137% 76.1% 68.9% 48.9% 42.6% 39.4% 35.5%
Net sales 1 37,417 44,351 45,811 54,073 58,739 63,245 66,851 71,298
EBITDA 1 7,586 9,237 13,580 16,691 19,476 22,269 24,395 26,750
EBIT 1 9,928 13,350 14,534 16,928 18,478 21,088 23,265 25,566
Net income 1 112 3,288 5,961 7,035 10,225 12,070 13,716 15,668
Net Debt 1 24,383 22,923 22,510 24,570 23,374 19,780 12,308 4,079
Reference price 2 117.51 135.16 135.02 131.05 185.60 160.54 160.54 160.54
Nbr of stocks (in thousands) 1,549,159 1,549,528 1,549,926 1,550,317 1,550,726 1,551,024 - -
Announcement Date 2/10/22 2/9/23 2/8/24 2/6/25 2/10/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
33.6x12.3x24.81x0.58% 1,057B
28.84x - - 2.07% 625B
32.43x7.35x15.3x2.81% 435B
20.47x4.85x12.02x2.72% 363B
22.14x5.72x14.28x2.8% 296B
20.58x4.25x12.07x2.07% 249B
25.76x6.78x12.06x2.45% 222B
13.84x4.97x10.44x3.68% 209B
-41.37x5.93x33.46x2.47% 165B
Average 17.37x 6.52x 16.80x 2.41% 402.31B
Weighted average by Cap. 24.45x 8.09x 18.31x 1.98%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield